Exact Mass: 211.0957

Exact Mass Matches: 211.0957

Found 22 metabolites which its exact mass value is equals to given mass value 211.0957, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

Zalcitabine

4-Amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2(1H)-one

C9H13N3O3 (211.0957)


A dideoxynucleoside compound in which the 3-hydroxyl group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of 5 to 3 phosphodiester linkages, which are needed for the elongation of DNA chains, thus resulting in the termination of viral DNA growth. The compound is a potent inhibitor of HIV replication at low concentrations, acting as a chain-terminator of viral DNA by binding to reverse transcriptase. Its principal toxic side effect is axonal degeneration resulting in peripheral neuropathy. [PubChem] J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D009676 - Noxae > D000963 - Antimetabolites > D015224 - Dideoxynucleosides D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors KEIO_ID Z001 Zalcitabine is a potent nucleoside analogue reverse transcriptase inhibitor used in the treatment of HIV infection.

   

N-Acetyl-1-methylhistidine

(2S)-2-acetamido-3-(1-methyl-1H-imidazol-4-yl)propanoic acid

C9H13N3O3 (211.0957)


N-Acetyl-1-methylhistidine belongs to the class of organic compounds known as histidine and derivatives. Histidine and derivatives are compounds containing histidine or a derivative thereof resulting from a reaction of histidine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N-Acetyl-1-methylhistidine is an acetylated derivative of 1-methylhistidine and a very strong basic compound (based on its pKa). It has been found to be associated with chronic kidney disease: the higher the N-acetyl-1-methylhistidine levels, the lower the estimated glomerular filtration rate. This could make N-acetyl-1-methylhistidine a biomarker for chronic kidney disease (PMID: 24625756).

   

N-Acetyl-3-methylhistidine

(2S)-2-Acetamido-3-(1-methyl-1H-imidazol-5-yl)propionic acid

C9H13N3O3 (211.0957)


N-Acetyl-3-methylhistidine, an N-acetyl-L-amino acid, belongs to the class of organic compounds known as histidine and derivatives. Histidine and derivatives are compounds containing histidine or a derivative thereof resulting from a reaction of histidine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N-Acetyl-3-methylhistidine is an acetylated derivative of 3-methylhistidine and a very strong basic compound (based on its pKa). N-Acetyl-3-methylhistidine has been found to be associated with prostate cancer (PMID: 28423352).

   

4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one

4-amino-1-[5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one

C9H13N3O3 (211.0957)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D009676 - Noxae > D000963 - Antimetabolites > D015224 - Dideoxynucleosides D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors

   

4-amino-1-(tetrahydro-5-hydroxy-2h-pyran-2-yl)-2(1h)-pyrimidinone

4-amino-1-(tetrahydro-5-hydroxy-2h-pyran-2-yl)-2(1h)-pyrimidinone

C9H13N3O3 (211.0957)


   

2,3-Dideoxycytidine

2,3-Dideoxycytidine

C9H13N3O3 (211.0957)


   

5-METHYL-6-(4-MORPHOLINYL)-2,4(1H,3H)-PYRIMIDINEDIONE

5-METHYL-6-(4-MORPHOLINYL)-2,4(1H,3H)-PYRIMIDINEDIONE

C9H13N3O3 (211.0957)


   

1-(2-amino-3,4-dioxocyclobuten-1-yl)-1-(2-methylpropyl)urea

1-(2-amino-3,4-dioxocyclobuten-1-yl)-1-(2-methylpropyl)urea

C9H13N3O3 (211.0957)


   

Ethyl (2-amino-4-hydroxy-6-methyl-5-pyrimidinyl)acetate

Ethyl (2-amino-4-hydroxy-6-methyl-5-pyrimidinyl)acetate

C9H13N3O3 (211.0957)


   

tert-butyl N-(5-formyl-1H-imidazol-2-yl)carbamate

tert-butyl N-(5-formyl-1H-imidazol-2-yl)carbamate

C9H13N3O3 (211.0957)


   

6-Dimethylamino-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxaldehyde

6-Dimethylamino-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxaldehyde

C9H13N3O3 (211.0957)


   

ethyl 2-dimethylamino-4-oxo-3H-pyrimidine-5-carboxylate

ethyl 2-dimethylamino-4-oxo-3H-pyrimidine-5-carboxylate

C9H13N3O3 (211.0957)


   

1H-PYRAZOLE-5-CARBOXALDEHYDE, 3-(1,1-DIMETHYLETHYL)-1-METHYL-4-NITRO-

1H-PYRAZOLE-5-CARBOXALDEHYDE, 3-(1,1-DIMETHYLETHYL)-1-METHYL-4-NITRO-

C9H13N3O3 (211.0957)


   

methyl 3-(2-amino-6-methyl-4-oxo-1H-pyrimidin-5-yl)propanoate

methyl 3-(2-amino-6-methyl-4-oxo-1H-pyrimidin-5-yl)propanoate

C9H13N3O3 (211.0957)


   
   
   

Zalcitabine

Zalcitabine

C9H13N3O3 (211.0957)


J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D009676 - Noxae > D000963 - Antimetabolites > D015224 - Dideoxynucleosides D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors Zalcitabine is a potent nucleoside analogue reverse transcriptase inhibitor used in the treatment of HIV infection.

   

4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one

4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one

C9H13N3O3 (211.0957)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D009676 - Noxae > D000963 - Antimetabolites > D015224 - Dideoxynucleosides D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors

   

N-Acetyl-3-methylhistidine

N-Acetyl-3-methylhistidine

C9H13N3O3 (211.0957)


   

N-Acetyl-1-methyl-L-histidine

N-Acetyl-1-methyl-L-histidine

C9H13N3O3 (211.0957)


An N-acetyl-L-amino acid that is N-acetyl-L-histidine in which the hydrogen attached to position 1 on the imidazole ring has been replaced by a methyl group.

   

N-Acetyl-3-methyl-L-histidine

N-Acetyl-3-methyl-L-histidine

C9H13N3O3 (211.0957)


An N-acetyl-L-amino acid that is N-acetyl-L-histidine carrying a methyl substituent at position 3 on the imidazole ring.

   

Cyclo(Asn-Pro)

Cyclo(Asn-Pro)

C9H13N3O3 (211.0957)